Blue Haven Rx review

The headline amounts have a three-month condition

Blue Haven Rx advertises compounded semaglutide from $149 per four weeks and tirzepatide from $179 per four weeks, tied to a three-month plan. The shorter-commitment rate is not publicly established in its public information. A reader should not treat either floor as a flexible calendar-month purchase without that condition.

Ask how much is collected at the start, when subsequent payments occur and what supply each buys. A plan term, billing interval and shipment schedule can describe different parts of the agreement. The three-month qualification needs to remain visible even if a product card calls the amount monthly or presents it as one simple inclusive price.

Four weeks changes the daily and annual comparisons

The program explicitly describes four weeks of medication. A $149 four-week charge is approximately $5.32 per day, so a less-than-$5 daily claim does not follow from that amount and period. Likewise, a continuous four-week cycle occurs thirteen times over 52 weeks, rather than twelve calendar-month renewals.

Those calculations explain the unit; they do not establish that the conditional plan will renew for an entire year at the same price. Obtain the actual payment agreement and maintenance terms before constructing an annual budget. A four-week supply also does not, on its own, define the usable period of an opened container; that comes from the pharmacy’s instructions.

The bundle names several useful inclusions

Blue Haven describes consultation, prescription, medication and free shipping within the advertised program, with the same price across doses. Confirm those inclusions for the selected term and prescribed formulation. A dose-flat promise can make one part of budgeting simpler while still leaving the required commitment or shorter-plan price unresolved.

Ask what clinical contact is available between shipments and how prescription changes are reviewed. Included consultation does not automatically establish a scheduled appointment every cycle, unlimited physician response or a particular consultation format. The service should identify what the patient can actually use, how to request it and whether any additional assessment creates another charge.

The facilitator, clinicians and pharmacy have distinct roles

The legal information names Eternum Health LLC, doing business as Blue Haven Rx, and identifies Wasef Health and Beluga Health as clinical organizations. The storefront describes itself as a facilitator rather than a medical practice. Ask which organization and clinician will hold the actual treatment relationship and how clinical questions reach them.

The site’s reference to 503A outsourcing facilities mixes pharmacy categories rather than clearly identifying the dispensing facility. Obtain the actual licensed pharmacy and product details instead of relying on that phrase. A compounded finished medication is not FDA-approved, regardless of a facility-related description, and should not inherit the approval status of a branded product containing a familiar ingredient.

Coverage and cancellation need their own written terms

Blue Haven describes service in all fifty states and Washington, D.C., without a public street address in its legal information. Confirm the selected prescription and contact arrangements for the intended location, and obtain the cancellation deadline and refund conditions before choosing a three-month plan. A contact email alone does not explain how to stop another order.

Its public material does not establish dedicated postpartum, breastfeeding or PCOS guidance. Blue Haven may interest someone comfortable with a qualified multi-month offer and an identifiable clinical service chain. The practical comparison needs the actual plan total, four-week unit, responsible pharmacy and usable follow-up, rather than an unqualified monthly price or daily-cost slogan.